The assay aims to identify and optimize specific modulators of human PI5P4K, a family of kinases that regulate AKT signaling and tumor cell growth, using a quantitative high-throughput screening approach against a chemical library of ~400,000 small molecules. Dysregulation of PI signaling is common in cancer and other diseases, therefore identifying inhibitors of human PI5P4K could have potential therapeutic implications. Is the molecule effective to this assay?